Drug
BoNT-A
BoNT-A is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
100%(2 trials)
Phase Distribution
Ph phase_2
3
75%
Ph not_applicable
1
25%
Phase Distribution
0
Early Stage
3
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
3(75.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(2)
Other(2)
Detailed Status
unknown2
Completed2
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 23 (75.0%)
N/A1 (25.0%)
Trials by Status
unknown250%
completed250%
Recent Activity
0 active trials
Showing 4 of 4
completednot_applicable
Dual-Site Botulinum Toxin Type A Injection for Lifelong Premature Ejaculation
NCT07426640
completedphase_2
"Follow the Sutures". A New Procedure for Injection of Botulinum Toxin for Chronic Migraine
NCT03543254
unknownphase_2
BotulInum Toxin Type A for Peripheral Neuropathic Pain in subjEcts With Carpal Tunnel Syndrome
NCT05411900
unknownphase_2
Kinematic-guided BoNT-A Treatment for ET and PD Tremor
NCT02427646
Clinical Trials (4)
Showing 4 of 4 trials
NCT07426640Not Applicable
Dual-Site Botulinum Toxin Type A Injection for Lifelong Premature Ejaculation
NCT03543254Phase 2
"Follow the Sutures". A New Procedure for Injection of Botulinum Toxin for Chronic Migraine
NCT05411900Phase 2
BotulInum Toxin Type A for Peripheral Neuropathic Pain in subjEcts With Carpal Tunnel Syndrome
NCT02427646Phase 2
Kinematic-guided BoNT-A Treatment for ET and PD Tremor
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4